Cogent Biosciences (COGT) Current Leases (2019 - 2021)
Cogent Biosciences (COGT) has 3 years of Current Leases data on record, last reported at $2.3 million in Q3 2021.
- For Q3 2021, Current Leases rose 13.33% year-over-year to $2.3 million; the TTM value through Sep 2021 reached $2.3 million, up 13.33%, while the annual FY2020 figure was $2.1 million, 26.74% up from the prior year.
- Current Leases reached $2.3 million in Q3 2021 per COGT's latest filing, up from $2.2 million in the prior quarter.
- Across five years, Current Leases topped out at $2.3 million in Q3 2021 and bottomed at $1.5 million in Q1 2019.
- Average Current Leases over 3 years is $1.8 million, with a median of $1.7 million recorded in 2020.
- Peak YoY movement for Current Leases: grew 10.02% in 2020, then increased 28.62% in 2021.
- A 3-year view of Current Leases shows it stood at $1.6 million in 2019, then rose by 26.74% to $2.1 million in 2020, then grew by 9.8% to $2.3 million in 2021.
- Per Business Quant database, its latest 3 readings for Current Leases were $2.3 million in Q3 2021, $2.2 million in Q2 2021, and $2.1 million in Q1 2021.